Participant retention
Of the 44,543 participants recruited into 12 months of follow-up at 135 SIREN sites, 37,725 (84.7%) completed their 12-months of follow-up (Table 2a). Extension into a second year of follow-up was offered at 87 SIREN sites, and 14,772 participants at these sites consented to extend their follow-up to 24 months. Of these, 12,635 (85.5%) participants completed their 24-month follow-up (Table 2b).
Table 2
a. Retention in the 12-month of follow-up cohort, by demographics, staff type and SIREN site size
Characteristic | Number of participants consented to 12 months of follow-up | Completed 12 months of follow-up n (%) | Odds ratio (OR) | 95% confidence interval | p-value |
Gender | | | | | |
Female | 36,852 | 31,348 (85.1) | Ref | Ref | Ref |
Male | 7,212 | 6,245 (86.6) | 1.13 | 1.04, 1.22 | 0.004 |
Other | 65 | 56 (86.2) | 1.33 | 0.66, 3.06 | 0.461 |
Age group | | | | | |
Under 25 | 1,741 | 1,333 (76.6) | Ref | Ref | Ref |
25 to 34 | 8,929 | 7,140 (80.0) | 1.18 | 1.04, 1.33 | 0.009 |
35 to 44 | 10,773 | 9,299 (86.3) | 1.86 | 1.64, 2.10 | < 0.001 |
45 to 54 | 13,082 | 11,596 (88.6) | 2.32 | 2.05, 2.63 | < 0.001 |
55 to 64 | 8,540 | 7,617 (89.2) | 2.50 | 2.19, 2.85 | < 0.001 |
Over 65 | 688 | 608 (88.4) | 2.34 | 1.81, 3.05 | < 0.001 |
Ethnicity | | | | | |
White | 38,680 | 32,858 (84.9) | Ref | Ref | Ref |
Asian | 3,238 | 2,861 (88.4) | 1.38 | 1.23, 1.56 | < 0.001 |
Black | 885 | 797 (90.1) | 1.64 | 1.30, 2.08 | < 0.001 |
Mixed Race | 680 | 570 (83.8) | 1.01 | 0.82, 1.26 | 0.894 |
Other Ethnic Group | 557 | 488 (87.6) | 1.23 | 0.95, 1.61 | 0.124 |
Prefer not to say | 89 | 75 (84.3) | 0.79 | 0.46, 1.48 | 0.436 |
Staff type | | | | | |
Nursing | 14,904 | 12,762 (85.6) | Ref | Ref | Ref |
Administrative/Executive | 6,653 | 5,609 (84.3) | 0.84 | 0.77, 0.91 | < 0.001 |
Doctor | 5,219 | 4,504 (86.3) | 1.01 | 0.92, 1.12 | 0.816 |
Healthcare Assistant | 3,647 | 3,078 (84.4) | 0.91 | 0.82, 1.01 | 0.088 |
Healthcare Scientist | 2,516 | 2,130 (84.7) | 1.00 | 0.89, 1.13 | 0.988 |
Student | 1,507 | 1,297 (86.1) | 1.02 | 0.88, 1.20 | 0.758 |
Therapist | 1,815 | 1,503 (82.8) | 1.01 | 0.88, 1.16 | 0.894 |
Midwife | 954 | 829 (86.9) | 1.19 | 0.98, 1.46 | 0.092 |
Pharmacist | 930 | 784 (84.3) | 1.06 | 0.88, 1.29 | 0.566 |
Estates/Porters/Security | 703 | 607 (86.3) | 0.99 | 0.78, 1.25 | 0.900 |
Other | 5,281 | 4,546 (86.1) | 1.07 | 0.98, 1.18 | 0.155 |
Site size (number of participants) | | | | | |
Small ≤ 200 | 5,203 | 4,445 (85.4) | Ref | Ref | Ref |
Medium 201–800 | 32,118 | 27,469 (85.5) | 1.00 | 0.91, 1.09 | 0.952 |
Large > 800 | 7,222 | 5,811 (80.5) | 0.75 | 0.68, 0.84 | < 0.001 |
Total | 44,543 | 37,725 (84.7) | | | |
Note: Ref = reference group | | | | |
Table 2
b. Retention in the 24-month of follow-up cohort, by demographics, staff type and SIREN site size
Characteristic | Number of participants consented to 24 months of follow-up | Completed 24 months of follow-up n (%) | Odds ratio (OR) | 95% confidence interval | p-value |
Gender | | | | | |
Female | 12,379 | 10,577 (85.4%) | Ref | Ref | Ref |
Male | 2,325 | 2,031 (87.4%) | 1.15 | 1.00, 1.32 | 0.054 |
Other | 20 | 18 (90.0%) | 1.33 | 0.37, 8.44 | 0.709 |
Age group | | | | | |
Under 25 | 233 | 176 (75.5) | Ref | Ref | Ref |
25 to 34 | 1,996 | 1,584 (79.4) | 1.23 | 0.89, 1.69 | 0.204 |
35 to 44 | 3,562 | 3,022 (84.8) | 1.80 | 1.30, 2.45 | < 0.001 |
45 to 54 | 5,118 | 4,540 (88.7) | 2.58 | 1.87, 3.51 | < 0.001 |
55 to 64 | 3,508 | 3,072 (87.6) | 2.34 | 1.69, 3.19 | < 0.001 |
Over 65 | 259 | 232 (89.6) | 2.92 | 1.78, 4.88 | < 0.001 |
Ethnicity | | | | | |
White | 13,009 | 11,071 (85.1) | Ref | Ref | Ref |
Asian | 965 | 875 (90.7) | 1.78 | 1.42, 2.25 | < 0.001 |
Black | 317 | 293 (92.4) | 2.12 | 1.41, 3.35 | < 0.001 |
Mixed Race | 217 | 196 (90.3) | 1.71 | 1.11, 2.78 | 0.021 |
Other Ethnic Group | 190 | 167 (87.9) | 1.23 | 0.81, 1.96 | 0.358 |
Prefer not to say | 26 | 24 (92.3) | 3.62 | 0.75, 65.1 | 0.209 |
Staff type | | | | | |
Nursing | 4,944 | 4,287 (86.7) | Ref | Ref | Ref |
Administrative/Executive | 2,357 | 1,968 (83.5) | 0.74 | 0.64, 0.85 | < 0.001 |
Doctor | 1,786 | 1,542 (86.3) | 0.86 | 0.73, 1.02 | 0.088 |
Healthcare Assistant | 972 | 845 (86.9) | 0.99 | 0.81, 1.22 | 0.933 |
Healthcare Scientist | 890 | 763 (85.7) | 0.98 | 0.79, 1.21 | 0.812 |
Student | 418 | 366 (87.6) | 1.17 | 0.86, 1.62 | 0.347 |
Therapist | 617 | 498 (80.7) | 0.76 | 0.61, 0.95 | 0.014 |
Midwife | 315 | 274 (87.0) | 1.01 | 0.73, 1.45 | 0.935 |
Pharmacist | 364 | 308 (84.6) | 0.90 | 0.67, 1.23 | 0.498 |
Estates/Porters/Security | 264 | 235 (89.0) | 1.11 | 0.75, 1.71 | 0.602 |
Other | 1,797 | 1,540 (85.7) | 0.98 | 0.84, 1.16 | 0.849 |
Site size (number of participants) | | | | | |
Small ≤ 200 | 1,920 | 1,642 (85.5) | Ref | Ref | Ref |
Medium 201–800 | 10,851 | 9,329 (86.0) | 1.05 | 0.91, 1.21 | 0.517 |
Large > 800 | 2,001 | 1,664 (83.2) | 0.86 | 0.72, 1.02 | 0.087 |
Total | 14,772 | 12,635 (85.5) | | | |
Participant retention decreased gradually over time (Fig. 2). Retention in the 12-month cohort was slightly higher among male participants compared to female participants (odds ratio (OR) = 1.13; 95% CI: 1.04–1.22; p = 0.004). Retention increased with age (55–64 years vs < 25 years OR = 2.50; 95% CI: 2.19–2.85; p < 0.001). Retention was highest in the Asian and Black ethnic groups (OR = 1.38; 95% CI: 1.23–1.56; p < 0.001, and OR = 1.64; 95% CI: 1.30–2.08; p < 0.001, respectively; reference group = White). Retention was similarly high across occupational groups, ranging from 83–87%. Retention varied over sites (range: 65.5–96.2%) and was higher among smaller sites (85.4% across sites < 200 participants vs. 80.5% sites > 800 participants; p < 0.001) (Table 2a).
Retention in the 24-month cohort followed a similar trend to the 12-month cohort, with retention increasing with age (> 65 years vs < 25 years OR = 2.92; 95% CI: 1.78–4.88; p < 0.001), and highest in the Asian and Black ethnic groups (OR = 1.78; 95% CI: 1.42–2.25; p < 0.001, and OR = 2.12; 95% CI: 1.41–3.35; p < 0.001, respectively; reference group = White). Trends in retention by staff group and site size followed the same trend as the 12-month cohort.
When analysed by time contributed to the study, participant withdrawals were highest in month 9 of follow-up for the 12-month cohort (791 withdrawals, 11.6%) and in month 21 of follow-up in the 24-month cohort (232 withdrawals, 10.9%). The median time in follow-up for those withdrawing from the 12-month cohort was 7 months (IQR: 4–10 months) and 19 months for those who withdrew from the 24-month cohort (IQR: 16–22 months). By calendar month, the withdrawal rate was highest in April 2021 (717 withdrawals, 1.6% of participants withdrawing), when 90% of participants had received their second vaccine dose (Fig. 2).
The most common reasons for withdrawal in both the 12- and 24-month cohorts were workload commitments (35.6% and 40.9%, respectively), and moving sites/leaving the NHS (18.5% and 22.5%, respectively) (Table 3).
Table 3
Number of withdrawals by reason, in the 12- and 24-month cohorts
Withdrawal reason | Withdrawals in 12-month cohort n (%) | Withdrawals in 24-month cohort n (%) |
Workload/work commitments | 2438 (35.8) | 879 (41.1) |
Moving sites/leaving NHS | 1303 (19.1) | 491 (23) |
Medical reasons | 756 (11.1) | 138 (6.5) |
Logistical issues with attending appointments | 622 (9.1) | 203 (9.5) |
Not stated | 383 (5.6) | 15 (0.7) |
Other | 316 (4.6) | 51 (2.4) |
Difficulties accessing testing | 296 (4.3) | 151 (7.1) |
Personal reasons | 189 (2.8) | 80 (3.7) |
Frequency of testing | 153 (2.2) | 37 (1.7) |
Dislike testing methods | 143 (2.1) | 12 (0.6) |
Ineligible | 109 (1.6) | 11 (0.5) |
Management of results | 47 (0.7) | 9 (0.4) |
Changes in attitudes towards the study over time | 34 (0.5) | 40 (1.9) |
Implication of results | 29 (0.4) | 20 (0.9) |
Total | 6,818 (100.0) | 2,137 (100.0) |
In terms of participant engagement with the study, among those who completed 12-months of follow-up, 98.1% of participants completed at least one fortnightly follow-up survey in the 12-months (median number of surveys completed: 24; IQR: 16–26). Among those who completed 24-months of follow-up, 99.9% of participants completed at least one fortnightly follow-up survey in the 24-months (median number completed: 49; IQR: 38–52).
Participant feedback survey
A total of 9,447 out of 32,845 participants (29%) completed the feedback survey. Respondents were representative of the SIREN cohort, predominately female (n = 8,004, 85%), with the highest percentage of respondents in the 35–44 age group (n = 3,635, 38%), nursing staff group (n = 3,203, 34%) and from South-West England (n = 1338, 14%).
The SIREN study scored highly across capability, opportunity and motivation categories and an overview of key survey results can be found in Table 4. In terms of participant capability [10], 90% of respondents found the study easy to participate in, and 90% understood how their data was being used and what it was contributing to. Responses to opportunity categories [10] were lower, with 66% reporting they were kept up to date about the study by their organisation and 70% agreeing that taking part in SIREN made them more aware of research at their organisation. SIREN scored highly across motivation categories [10]: 93% agreed that SIREN made them feel like they were making a valuable contribution to the pandemic response; 87% agreed that participating reassured them about their COVID-19 status and 86% felt like a valued member of the study.
Table 4
Results of the SIREN participant feedback survey
FEEDBACK STATEMENT | Agree | Neutral | Disagree |
n (%) | n (%) | n (%) |
COM-B component: Capability | | | |
I know where to go to find information about the SIREN study | 7801 (83.1) | 1284 (13.7) | 302 (3.2) |
I know where to go to ask any questions I have about the SIREN study | 7722 (82.5) | 1293 (13.8) | 345 (3.7) |
I understand how my data is being used and what it is contributing to | 8257 (90.0) | 768 (8.4) | 167 (1.8) |
| Easy | Neutral | Difficult |
n (%) | n (%) | n (%) |
I found the SIREN study…to participate in | 8289 (90.2) | 792 (8.6) | 107 (1.1) |
| Agree | Neutral | Disagree |
n (%) | n (%) | n (%) |
COM-B component: Opportunity | | | |
Being part of the SIREN study has made me more aware of research going on in my own organisation | 6474 (70.3) | 2245 (24.3) | 482 (5.3) |
I am kept up to date with information about the SIREN study by my organisation | 6137 (65.6) | 1862 (19.9) | 1362 (14.5) |
I am kept up to date with information about the SIREN study by the UKHSA SIREN study team | 7866 (85.8) | 1134 (12.4) | 169 (1.8) |
COM-B component: Motivation | | | |
Participating in the SIREN study to date has made me more likely to participate in future research studies | 7153 (77.7) | 1965 (21.3) | 86 (1.0) |
Participating in the SIREN study makes me feel like I am making a valuable contribution to the COVID-19 pandemic response | 8581 (93.4) | 564 (6.1) | 39 (0.5) |
Being testing regularly as part of the SIREN study has made me feel more reassured about my COVID-19 status | 8019 (87.2) | 1028 (11.2) | 151 (1.6) |
I have felt like a valued member of the SIREN study | 7896 (86.2) | 1191 (13.0) | 71 (0.8) |
Analysis of open text responses for participants who felt like valued members of the SIREN study highlighted the following four key themes.
Theme 1 (positive): the role of friendly and welcoming local site teams
An approachable and friendly site team willing to be flexible was a recurrent theme:
The team are welcoming and even accommodate my working pattern so I can do the tests.
A very friendly team that makes you feel valued.
Theme 2 (positive): positive communication from the study
Participants valued the communication provided by the study team, including updates on the research and the acknowledgement of participant contributions.
Regular communication from SIREN which always included a thank you. Have also joined/watched all of the webinars which have always stressed the value of every single test sample submitted.
SIREN team have been brilliant at keeping participants involved and aware of the part their contribution plays.
Theme 3 (positive): contributing to the COVID-19 pandemic response
Recognition of the contribution the study made to the national pandemic response was another motivating factor for participants.
The information provided has hopefully made a difference to the approach to managing and minimising the effect of COVID.
Seeing Chris Whitty quote results has really made me feel like I am contributing to something which directly relates to decisions made about wider society.
Theme 4 (positive): contributing to research
A final positive theme emerging from participant feedback was of the contribution that SIREN provided to research nationally and internationally.
It helps the global community get the relevant information …and hopefully prepare communities on dealing with other viruses.
It is good to be part of the study to help future studies.
The following four themes emerged from analysis of responses from individuals who did not feel like valued members of the SIREN study.
Theme 1 (negative): inflexibility in local study arrangements
A lack of flexibility for testing appointments had a negative impact for participants.
So unfortunately, the research unit where I work have become very inflexible and will only do swabs and bloods on the two days a week when I don’t work.
Was given no more than 48 hours’ notice for appointments.
Theme 2 (negative): poor communication
For some participants, communication about the study was inadequate and negatively impacted their experience of being a study participant.
I do not feel the results are clearly disseminated – although I see sporadic emails announcing a Webinar regarding this study, I do not feel or understand the benefit of being part of this study.
I didn’t receive the text messages promised and when I asked about this had no response.
Theme 3 (negative): lack of individualised test results
Some participants were unhappy with the individualised test result reporting available at their site.
There has been very little feedback from any of my tests. Simply being told that if a PCR was positive I’d be told, is less reassuring that being actively told each result when it was known.
Theme 4 (negative): the study closing at SIREN sites
Termination of the study at individual sites, which may have occurred abruptly was described negatively by some participants.
I couldn’t continue after the study closed at my site. I would have liked the opportunity to continue.
The way it ended abruptly with no prior warning or explanation made me feel undervalued.
Participant feedback at withdrawal
Analysis of open text responses captured via the withdrawal survey demonstrates many participants who withdrew from the study had a positive experience (49%, n = 797), with 38% (n = 617) reporting a neutral experience and 12% (n = 202) reporting a negative experience. Analysis of responses using the COM-B framework provides further detail on factors impacting participant capability, opportunity and motivation to be a part of the study, with many similarities in themes between feedback from participants active in the study (above) and those who withdrew. Themes relating to opportunity and motivation were cited more frequently than capability. Participants who withdrew valued the opportunity to contribute to the pandemic response and acknowledged the scientific importance of SIREN research as motivating factors. Negative factors included finding the study burdensome and feeling dissatisfied with the availability or granularity of individualised test result reporting available at their site.
Site research team feedback
Two focus groups with attendees from SIREN site teams took place to explore factors associated with participant retention. Twelve site team members representing nine SIREN sites attended a focus group. Most participants were female (92%, n = 11), white (83%, n = 10) and all aged 35 or above.
Respondents described considerable variation in how SIREN was delivered locally across sites and how participant retention was managed.
A key observation was that participant motivation for remaining in the study changed as the pandemic progressed, and local teams had to adapt their retention strategies in response. Initially, site teams reported that many SIREN participants reported that their primary motivation for taking part in SIREN was not the individual protection it provided, but the ability to contribute to the evidence base about COVID-19. As this was a novel disease, participants felt their contributions were particularly crucial to understand more about it and provide more certainty to wider society.
In addition, access to PCR and antibody testing was a motivator to join the study, as a means of helping keep families and patients safe and understanding their own immunity (antibody) and as an enabler for activities during a period of restrictions.
We had a lot of people that were quite interested at the beginning. Very keen, actually. We almost got overrun with it. And I think because there wasn't any swabbing, there wasn't lateral flows back then. The only thing you could do was have a PCR test, and they weren't that easy to get, I seem to recall. So we had a lot of people that were very interested because simply the fact that they could assure the safety of their family every two weeks. That seems to be the big motivation. And I'm going to say, unashamedly, we played on that a little bit, and it worked.
(Focus Group 1)
With the availability of Lateral Flow Devices (LFDs) to the public, respondents observed that for some participants the value of PCR testing through SIREN was reduced. Changes in hospital staff testing policies and the introduction of policies for regular LFD testing also had consequences for SIREN participation.
The lateral flow that the trust mandated for all clinical staff took precedence, and people suddenly started to see the SIREN study as optional, which it is optional, of course. But they started to see it as, well I did my lateral flow yesterday so why do I need to bother doing a PCR today when my lateral flow was negative, so they stopped doing it that way.
(Focus Group 1)
Factors perceived to impact participant motivation over time were primarily external to the study, such the availability of SARS-CoV-2 testing outside the study, the introduction of COVID-19 vaccination, and changing pandemic control measures – with the removal of non-pharmaceutical interventions and increased social mixing over time. These external changes appeared to reduce threat perception to SARS-CoV-2 and impact participant perceptions of the value of the study.
In addition to these external factors, respondents also identified challenges internal to the study, with participants dropping out of the study due to the physical discomfort of testing, the negative impact of having to take time-off work due to a positive test, and fatigue from attending so many SIREN appointments.
Focus group respondents described how they adapted the retention strategies over time in response to changing participant motivations. When asked for examples of what worked well, the following themes emerged.
Theme 1: Share study findings with participants
Focus group respondents described how it was important to communicate study findings with participants. Examples were given where site teams had shared presentations of localised data with participants to demonstrate the wider value of their individual contribution. Site teams felt it was important to share this information as the initial reason for taking part was no longer fulfilled by SIREN alone and participants needed something more in return for their contribution to the study.
So then we changed our strategy a little bit, and we shared some of the information about the inputs of the study, some of the things that the preliminary stuff that started to come out, so the people could see that it was bigger than just them. And that actually it was really important that they kept contributing.
(Focus Group 1)
Theme 2: Convenience as a facilitator for retention
Focus group respondents considered that the consistency and physical location of SIREN activities had important implications for retention. Better engagement was reported when the local SIREN team (and clinic) was physically closer to the hospital. Reducing the amount of travel required and co-locating services was identified as helping with retention as it minimised the testing burden of time and distance travelled. Respondents described a range of retention strategies used across the different research sites to increase the convenience of study participation. This included flexible delivery models such as drop-in and fixed appointments to accommodate the needs of participants different shift patterns and preferences, and timely communications with reminders and results as external prompts to remain engaged.
The pathology department is right by phlebotomy, so they could then go and get their blood test done. So it was actually only really one trip, and they could get everything done in that one area. And I think that helped with retention.
(Focus Group 2)
Theme 3: Incentives and tokens of appreciation as facilitators
Respondents discussed that incentives such as raffles and tokens of appreciation such as cupcakes, badges and certificates created opportunities for positive and engaging communications.
SIREN provided us with some certificates for all the participants as well as there were little badges that they could wear around... They were so inspired by it all, they were wearing it with pride and those who did not get one were complaining that they didn't get. But it was very helpful to have that little bit of incentive.
(Focus Group 1)
However, with the scale of SIREN and limited budget, opportunities for offering these were limited, and some respondents voiced frustration at the quality and quantity of tokens provided by the central team. While incentives were recognised as positive for motivation, site teams felt maintaining a relationship with participants was more important for retention and maximising participation.